Kiadis Pharma Successfully Prices Initial Public Offering on Euronext at EUR 12.50 Per Share Raising EUR 32.7m
NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE...